Dow Jones Newswires: Roche gets FDA Emergency Use Authorization for Monkeypox virus test


Roche Holding AG said Wednesday that its monkeypox virus test has received emergency use authorization by the U.S. Food and Drug Administration.

Cobas MPXV is a real-time PCR test which detects the presence of monkeypox virus DNA from lesion swabs, the Swiss medical company


The test targets two different regions of the virus’ genome, both of which are less prone to mutation, ensuring the test will continue to identify cases of the virus even in the event of a mutation in one of the test’s target zones, Roche said.

The test received emergency use authorization by the U.S. regulator after evaluating results from samples taken from patients, rather than from a laboratory, Roche said.

Write to Pierre Bertrand at

Dow Jones Newswires: Siemens Energy: No dividend proposed for FY22 due to net loss, expected challenges

Previous article

NerdWallet: 5 common pitfalls of ‘buy now, pay later’ and how to avoid them this holiday season

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News